Free Trial

Zacks Research Comments on Ameren's Q2 Earnings (NYSE:AEE)

Ameren logo with Utilities background
Remove Ads

Ameren Co. (NYSE:AEE - Free Report) - Stock analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for shares of Ameren in a research note issued on Wednesday, April 2nd. Zacks Research analyst R. Department now anticipates that the utilities provider will post earnings per share of $0.84 for the quarter, down from their prior forecast of $0.91. The consensus estimate for Ameren's current full-year earnings is $4.93 per share. Zacks Research also issued estimates for Ameren's Q3 2025 earnings at $1.66 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $4.90 EPS, Q1 2026 earnings at $1.33 EPS, Q1 2027 earnings at $1.44 EPS and FY2027 earnings at $5.69 EPS.

Ameren (NYSE:AEE - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The utilities provider reported $0.77 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.83 by ($0.06). Ameren had a net margin of 15.51% and a return on equity of 10.34%. During the same quarter last year, the firm earned $0.60 EPS.

A number of other equities research analysts have also commented on the company. Barclays lowered their price target on Ameren from $102.00 to $101.00 and set an "equal weight" rating for the company in a research report on Tuesday. Evercore ISI upgraded shares of Ameren from an "in-line" rating to an "outperform" rating and increased their target price for the company from $89.00 to $104.00 in a report on Tuesday, January 21st. Morgan Stanley boosted their price target on shares of Ameren from $97.00 to $101.00 and gave the stock an "equal weight" rating in a report on Thursday, March 20th. BMO Capital Markets lifted their target price on shares of Ameren from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 18th. Finally, UBS Group upped their target price on Ameren from $106.00 to $113.00 and gave the company a "buy" rating in a report on Friday, March 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Ameren presently has an average rating of "Moderate Buy" and an average target price of $96.60.

Remove Ads

Read Our Latest Stock Analysis on AEE

Ameren Stock Up 2.7 %

Shares of Ameren stock traded up $2.55 on Friday, hitting $96.78. The company had a trading volume of 652,448 shares, compared to its average volume of 1,562,789. The stock has a market capitalization of $26.12 billion, a price-to-earnings ratio of 21.88, a P/E/G ratio of 2.97 and a beta of 0.45. The company has a debt-to-equity ratio of 1.41, a quick ratio of 0.44 and a current ratio of 0.66. Ameren has a 1 year low of $69.39 and a 1 year high of $104.10. The stock has a 50 day moving average of $98.26 and a 200-day moving average of $92.77.

Ameren Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Tuesday, March 11th were paid a dividend of $0.71 per share. This is an increase from Ameren's previous quarterly dividend of $0.67. The ex-dividend date was Tuesday, March 11th. This represents a $2.84 annualized dividend and a dividend yield of 2.93%. Ameren's dividend payout ratio is presently 64.25%.

Insider Activity at Ameren

In related news, EVP Chonda J. Nwamu sold 5,500 shares of the business's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $101.37, for a total transaction of $557,535.00. Following the sale, the executive vice president now directly owns 43,344 shares in the company, valued at approximately $4,393,781.28. The trade was a 11.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Craig S. Ivey sold 2,716 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $98.27, for a total value of $266,901.32. Following the completion of the transaction, the director now owns 14,495 shares of the company's stock, valued at approximately $1,424,423.65. This represents a 15.78 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,959 shares of company stock worth $1,316,712. Company insiders own 0.34% of the company's stock.

Institutional Investors Weigh In On Ameren

A number of institutional investors and hedge funds have recently modified their holdings of AEE. Synergy Investment Management LLC purchased a new stake in Ameren in the 4th quarter worth approximately $25,000. Roxbury Financial LLC bought a new position in shares of Ameren in the fourth quarter worth $27,000. Quarry LP purchased a new stake in shares of Ameren in the fourth quarter worth $31,000. Lee Danner & Bass Inc. bought a new stake in Ameren during the fourth quarter valued at $38,000. Finally, Optiver Holding B.V. grew its position in Ameren by 78.7% during the fourth quarter. Optiver Holding B.V. now owns 470 shares of the utilities provider's stock worth $42,000 after buying an additional 207 shares in the last quarter. 79.09% of the stock is owned by hedge funds and other institutional investors.

About Ameren

(Get Free Report)

Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.

Further Reading

Earnings History and Estimates for Ameren (NYSE:AEE)

Should You Invest $1,000 in Ameren Right Now?

Before you consider Ameren, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.

While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads